跳至主要内容
临床试验/NCT03946826
NCT03946826已完成不适用

A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis: a Single-blind, Randomized, Self-controlled Trial

xjpfW0 个研究点目标入组 20 人开始时间: 2015年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
主要终点
NAPSI score

研究概览

简要总结

  1. Psoriasis is a common chronic, inflammatory disease characterized by skin changes and joint involvement. About 50% of patients with psoriasis have damage to the nail, especially in pustular psoriasis in the continuous acromegaly dermatitis. Common damage includes pitting, uneven and tarnish of the deck, as well as the occurrence of nail ridges, furrows, turbidity, hypertrophy, free ends and nail bed stripping, and even the whole deck deformity or absence, etc., seriously affecting patients' social interaction and mental health. Pathologically, telangiectasis is associated with the superficial and middle layers of the dermis. Previous treatment of psoriasis nail is mainly topical drugs (such as glucocorticoid, etc.), but due to its long disease period, topical drugs are difficult to transdermal absorption, and the curative effect of skin lesions is poor.
  2. Pulsed dye laser (PDL) is effective for vasodilatory diseases, especially for the superficial to middle layers of the dermis
  3. It has been reported that PDL is effective in the treatment of psoriasis vulgis by blocking the nutrient supply vessels of the lesions, improving the surrounding microenvironment, reducing the number of cytotoxic T cells and helper T cells in the dermis, and promoting the normalization of epidermal proliferation and differentiation.
  4. Halometasone is a potent halogen - containing topical glucocorticoid. Have stronger fight inflammation, fight allergy, contractive hemal, reduce hemal to connect the action of permeability and fight hyperplasia Vaseline belongs to a kind of mineral wax, without irritant, not easy to deteriorate, can let skin surface form a protective film when used on the skin, let the moisture of the skin be evaporated not easily, have better protect wet effect.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • .subjects must be clinically diagnosed by the investigator to have nail psoriasis .All nails have psoriasis on both hand.Males or females, 18 Years to 65 Years of age at the time of signing the informed consent document.
  • .No other external treatment was performed before the injury was treated. .The condition of no rupture or infection in the skin affected the field of vision of laser operation.
  • .The patient has no history of treatment of biological preparations, such as Indolisimab, etc.
  • .Check blood routine, liver and kidney function, normal blood sugar, female urine pregnancy test negative during childbearing age.
  • .Understand and voluntarily sign an informed consent document prior to any study related assessments/procedures being conducted.

排除标准

  • Pregnant or lactating women with a history of light sensitivity;
  • The patient has just stopped or started new systemic treatment; Patients with serious infectious diseases;
  • suffering from severe diabetes, severe cardiovascular disease and connective tissue disease;
  • patients with a history of active tuberculosis, blood diseases, and epilepsy;
  • There are infected persons and patients with acute infectious diseases in the treatment site;
  • Patients who are considered by the researchers to be unfit to participate in this experiment

研究组 & 干预措施

PDL+ Halometasone Cream group

Experimental

PDL+ Halometasone Cream Halometasone Cream, bid ,external use for 6 months; 3 nails were randomly selected to be treated with PDL laser therapy (6ms, 11±2J/cm2) once a month for a total of 6 times

干预措施: Halometasone Cream (Drug)

PDL+ Halometasone Cream group

Experimental

PDL+ Halometasone Cream Halometasone Cream, bid ,external use for 6 months; 3 nails were randomly selected to be treated with PDL laser therapy (6ms, 11±2J/cm2) once a month for a total of 6 times

干预措施: Pulsed dye laser (PDL) (Radiation)

PDL+Vaseline group

Experimental

PDL+Vaseline Vaseline, bid ,external use for 6 months; 3 nails were randomly selected to be treated with PDL laser therapy (6ms, 11±2J/cm2) once a month for a total of 6 times

干预措施: Vaseline (Drug)

PDL+Vaseline group

Experimental

PDL+Vaseline Vaseline, bid ,external use for 6 months; 3 nails were randomly selected to be treated with PDL laser therapy (6ms, 11±2J/cm2) once a month for a total of 6 times

干预措施: Pulsed dye laser (PDL) (Radiation)

Halometasone Cream

Active Comparator

Halometasone is a potent halogen - containing topical glucocorticoid. Have stronger fight inflammation, fight allergy, contractive hemal, reduce hemal to connect the action of permeability and fight hyperplasia

干预措施: Halometasone Cream (Drug)

Vaseline

Placebo Comparator

Vaseline belongs to a kind of mineral wax, without irritant, not easy to deteriorate, can let skin surface form a protective film when used on the skin, let the moisture of the skin be evaporated not easily, have better protect wet effect

干预措施: Vaseline (Drug)

结局指标

主要结局

NAPSI score

时间窗: Change from Baseline to 1 year

1. Nail matrix score: according to the proportion of nail matrix damage (puncture, meniscus with all white and red spots, and nail fragmentation) to the nail matrix content, 0 means no, 1 means 1/4 nail, 2 means 2/4 nail, 3 means cumulative 3/4 nail, and 4 means total nail. 2. Nail bed score: the nail bed damage (nail dissection, puncture hemorrhage, hyperkeratosis under the nail, salmon spot) is graded according to the proportion of the nail bed. 0 means no, 1 means 1/4 nail, 2 means 2/4 nail, 3 means cumulative 3/4 nail, and 4 means total nail. 3. Single nail score is the sum of nail matrix score and nail bed score (0-8 points), The final score is the sum of all single nail scores (0-80), and the nail score can be conducted at any time as required.

次要结局

  • VAS Pain Assessment(Change from Baseline to 6 months)

研究者

发起方
xjpfW
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

xjpfW

Head of Dermatology

Xijing Hospital

相似试验